Back to results
US 11,026,912 B2Granted
Azelaic acid esters in the treatment of insulin resistance
AssigneeNew Frontier Labs, LLC
InventorsRobert T. Streeper, Elzbieta Izbicka
Life of this patent
Estimating the term…
Abstract
A method of treating insulin resistance includes administering to a subject a pharmaceutical composition comprising diethyl azelate. For example, a method of treating insulin resistance includes orally administering to a subject a pharmaceutical composition that includes diethyl azelate at a dosage range from about 0.1 mg/kg/day to about 10 mg/kg/day.
Claims13
A method of treating Type 2 diabetes comprising administering to a subject a pharmaceutical composition comprising diethyl azelate at a dose in a range from 0.5 mg/kg/day to 2.5 mg/kg/day.
Dependencies are inferred from the claim text.